Mayuree Jirapinyo MD*, Jittima Manonai MD*, Yongyoth Herabutya MD*, Suporn Chuncharunee MD**
Affiliation : * Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University ** Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Background : Recombinant activated factor VII is used for the treatment in patients with inherited or acquired
hemophilia with inhibitors and congenital factor VII deficiencies.
Objective : Using recombinant activated factor VII in primary postpartum hemorrhage.
Materials and Methods : Two cases of women who had postpartum hemorrhage and were treated with recombi-
nant activated factor VII after all conventional treatment failed.
Results : The intractable hemorrhage stopped after treatment with recombinant activated factor VII
Conclusion : The present report showed that massive postpartum hemorrhage that failed to all procedures was
controlled successfully by recombinant activated factor VII
Keywords : Intractable postpartum hemorrhage, Recombinant activated factor VII, rFVIIa
JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
4th Floor, Royal Golden Jubilee Building,
2 Soi Soonvijai, New Petchburi road,
Bangkok 10310, Thailand.
Phone: 0-2716-6102, 0-2716-6962
Fax: 0-2314-6305
Email: editor@jmatonline.com
» Online Submissions » Author Guidelines » Copyright Notice » Privacy Statement
» Journal Sponsorship » Site Map » About this Publishing System
© MEDICAL ASSOCIATION OF THAILAND. All Rights Reserved. The content of this site is intended for health professionals.